Clazakizumab ELISA Kit
Product Specifications
Background
Clazakizumab, a humanized anti–IL-6 mAb, is used in the phase II clinical trial for the treatment of RA patients. It has also been evaluated for the treatment of non-small cell lung cancer (NSCLC) and patients with head and neck cancer.
Specifications
Clazakizumab
Product Name Alternative
ALD-518, BMS-945429, CAS: 1236278-28-6
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
